Latest Updates
-
Anupama Parameswaran Talks About Love, Control, and Finally Walking Away -
Migraine or Brain Tumour? The Headache Symptoms Doctors Say Not to Ignore -
OTT Releases This Week (10 To 17 August): What To Stream On Netflix, Prime, JioHotstar, Zee5 And SonyLIV -
Throwback Thursday: On Sridevi’s 63rd Birth Anniversary, Movies That Made Her Bollywood’s First Lady Superstar -
Why Your Skincare Might Be Silently Damaging Your Skin's pH Balance -
Are Artificial Sweeteners Safe For Diabetics? The Truth About Sugar-Free Alternatives -
Skipping Rice To Avoid Diabetes? Debunking The Common Myth People Still Believe -
Recurring Chest Infections: Expert Explains If It Could Be a Sign of Lung Cancer? -
Solar Eclipse 2026: Date, Time And Livestream Details For India -
Cristiano Ronaldo And Georgina Rodríguez Are Married After Ten Years Together
Scorpion Venom May Help Fight Brain Cancer

Researchers have found a brain-cancer therapy which uses a radioactive version of a protein found in scorpion venom. Traditional treatments like radiation and chemotherapy kill healthy cells in the process of controlling the cancer growth.
The sting of the scorpion Leiurus quinquestriatus unleashes a cocktail of neurotoxins containing a peptide that is non-toxic to humans but binds to tumour cells. In tests, the peptide has invaded tumours in breast, skin, brain and lung tissue while leaving healthy cells untouched.
"It's as if the tumours collect it," New Scientist quoted Michael Egan of the company TransMolecular in Cambridge, Massachusetts, as saying.
To determine if the peptide could deliver lethal doses of radioactivity to cancer cells, researchers have now attached radioactive iodine isotopes to it.
In an experiment, the researchers injected this agent directly into the tumours of 59 people suffering from inoperable brain cancer. All the patients have now died, but those receiving a higher dose lived for three months longer, on average.
Researchers at the University of Chicago in Illinois have begun injecting TM601 into the bloodstream of people with different types of malignant brain cancer. This latest trial will allow the company to test whether it can seek out and kill secondary tumours throughout the body, as well as known primary ones.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications